This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Health technology
The use of two protocols for ovarian stimulation in infertile couples undergoing intrauterine insemination after clomiphene citrate (CC) failure. The protocols compared were minimal stimulation versus full stimulation. Under the minimal stimulation protocol, women were given 100 mg CC during cycle days 3 to 7, followed by a single injection of 150 IU human menopausal gonadotrophin (hMG). The full protocol consisted of 100 mg/day CC on days 3 to 7 and 75 to 150 IU/day hMG on days 5 to 9, while further hMG dosage was adjusted according to follicular monitoring.
Type of intervention
Treatment.
Economic study type
Cost-effectiveness analysis.
Study population
The study population comprised couples suffering from idiopathic or unexplained infertility and undergoing intrauterine insemination. In particular, the following inclusion criteria were considered: infertility of at least 2 years; normal history and physical examination; adequate coital frequency; normal semen analysis; regular ovulatory menstrual cycles; adequate cervical mucus and a normal postcoital test; normal levels of follicle stimulating hormone, leutinising hormone, prolactin, and thyroid stimulating hormone; normal hysterosalpingography and/or laparoscopy.
The criteria for CC failures were anovulatory women who ovulated with CC but fail to conceive in 5 or 6 cycles, and women with unexplained infertility who had been given CC empirically.
Study design
This was a prospective, randomised clinical trial that was conducted in a single centre, the Department of Obstetrics and Gynaecology of Nehru Hospitals in Chandigarh. The patients were allocated to the study groups using a random table before starting the first cycle of ovarian stimulation. The length of follow-up was not reported. No loss to follow-up was observed. The outcome assessment was not blinded.
Analysis of effectiveness
The analysis of effectiveness appears to have been conducted on an intention to treat basis, as all the patients included in the initial study sample were accounted for in the effectiveness study. The outcomes estimated in the analysis were: the number of dominant follicles, the number of visits for monitoring, the number of ampoules of hMG (75 IU), the pregnancy rate per couple and per cycle, the rate of abortion, the rate of multiple gestation, and the incidence of hyperstimulation.
The two groups were comparable in age, years of infertility, type of infertility, or indication for treatment.
Effectiveness results
There were 1.83 (+/-0.71) dominant follicles in the minimal stimulation group versus 3.16 (+/-1.50) in the full stimulation group.
There was 1 visit for monitoring in the minimal stimulation group versus 3.15 (+/-1.21) in the full stimulation group.
The number of ampoules of hMG (75 IU) was 2 in the minimal stimulation group versus 12 (+/-5.4) in the full stimulation group, (p<0.01).
